Skip to content

CBD Is a Novel Food, but What Does That Mean and Why Does It Matter?

"Novel food" is a classification for food or food ingredients in the European Union (EU). The import and sale of novel foods are regulated in the EU, and noncompliance can result in enforcement by EU Member States or the United Kingdom (UK). Online merchants selling food products or dietary supplements often ship worldwide, including the EU. This makes it important for payment service providers in the United States to know if their merchants are shipping novel foods, such as cannabidiol (CBD), to EU countries.

 

What are novel foods?

Novel foods can be newly developed food, food produced by new technologies or processes, or food that has traditionally been eaten outside the EU. The concept of a "novel food" is not new. Throughout history, new types of food, food ingredients, or processes for producing food have found their way to Europe from all around the world. Bananas, tomatoes, rice, and a wide range of spices all originally came to Europe as new foods. An example of a novel food that has recently increased in popularity is chia seed.

Before novel foods can be placed on the EU market, pre-market authorization by the European Commission is required.

 

What is CBD's novel food status?

The Novel Food Catalogue explicitly includes cannabinoids such as CBD as unauthorized novel foods, "as a history of consumption has not been demonstrated." This means that without a prior authorization, CBD is not allowed to be included in any food or dietary supplements in the EU. Currently, there are multiple ongoing applications for the authorization of CBD as an approved novel food.

There appear to be varying approaches and timelines for enforcement among EU Member States and the UK. In Germany, for example, the Federal Office of Consumer Protection and Food Safety states that products containing CBD must either be submitted for approval as a medicinal product or for approval as a novel food before they are placed on the market. In addition, the German Federal Government supports the decision of the European Commission to include CBD as novel food in the EU Novel Food Catalogue.

In the UK, the Food Standards Agency (FSA) states that CBD has novel food status. On February 13, 2020, the FSA announced a deadline of March 31, 2021, for companies marketing CBD extracts as foods or food supplements industry to submit novel food authorization applications. After this date, the FSA stated that only products with a fully validated novel food authorization application will be permitted, and all other novel CBD products will be removed from sale.

 

Why should companies in the United States care?

Many online merchants selling food and dietary supplements may be based in the US or other parts of the world but ship to the EU. This is why it is important for payment service providers, e-commerce platforms, and online marketplaces to be aware of the laws that govern these products, even if their merchants' core business is not in the EU. Selling products containing unauthorized novel foods may lead to enforcement by local authorities of EU member states. Merchants are generally obligated to verify whether food products that they sell require pre-market authorization.

 

To learn more about the regulation of novel foods, download our Novel Foods FAQ.


Cover of LegitScript's Novel Food Guide showing various ingredients

Recent Blog Articles

Dan Frechtling, LegitScript

Merchant Monitoring and the Power of AI + Human Expertise: A Conversation with Dan Frechtling

In the fast-evolving world of payments, managing merchant risk has never been more critical-or more complex. We sat down with Dan Frechtling, LegitScript's Senior Vice President of Product and Strategy, to discuss what sets LegitScript apart in the merchant monitoring landscape. In this Q&A, Dan...

How LegitScript Complies with Mastercard’s Merchant Monitoring Program (MMP)

What You Need to Know The latest revision to Mastercard's Merchant Monitoring Program (MMP) signals a major shift in how payments companies must manage compliance. The updated rules raise expectations for both onboarding and ongoing oversight, requiring acquirers to demonstrate deeper visibility int...

Deepfake; Real Risk: The Crackdown on AI Image Generators

AI has transformed how people create and share digital content. But as AI tools evolve, they're also creating new compliance and reputational risks. LegitScript has seen an increase in card network scrutiny related to AI image generation and deepfakes. Our analysts are monitoring the swiftly changin...

Where Policy Meets Performance: Winning in Healthcare Advertising Post-Certification

Why LegitScript Certification Matters for Healthcare Advertising For many healthcare providers, earning LegitScript Certification is a major milestone. It's the key that unlocks advertising on platforms like Google and Meta, two of the most powerful digital channels for reaching patients. Certificat...